Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Health Psychol Res ; 11: 84273, 2023.
Article in English | MEDLINE | ID: mdl-37670795

ABSTRACT

Heavy societal stigma of certain conditions has created an environment where individuals may be hesitant to seek professional care. Urology is a specialized field that focuses on many of these conditions that society has deemed taboo to discuss. In this review, we address barriers that have prevented patients from seeking urologic care in order to better understand and elucidate important concerns within development of the physician-patient relationship. Recognizing these concerns can also assist in public health outreach approaches to motivate patients for seeking urologic care. The scope of this review was limited to three highly prevalent conditions affecting both men and women, including urinary incontinence, erectile dysfunction, and genitourinary syndrome of menopause.

2.
J Addict Med ; 17(2): 147-154, 2023.
Article in English | MEDLINE | ID: mdl-36001073

ABSTRACT

BACKGROUND: Cocaine use exacerbates human immunodeficiency virus (HIV)-associated subclinical coronary atherosclerosis. We investigated whether cocaine abstinence or reduced use achieved with contingency management (CM) intervention would retard high-risk coronary plaque progression among cocaine users with HIV and subclinical coronary atherosclerosis. METHODS: Between March 2014 and August 2017, 76 cocaine users with HIV and coronary plaques were enrolled in a study designed to decrease cocaine use and determine whether doing so impacted progression of subclinical coronary atherosclerosis as measured by coronary artery computed tomography examinations. Of the 76, 7 did not complete the study, resulting in 69 participants. A 12-month cash-based CM intervention was implemented to promote cocaine abstinence or reduced cocaine use. Generalized estimating equation approach was used to perform longitudinal data analyses. FINDINGS: During the 12-month CM, all 69 participants reduced cocaine use, and of these, 25 (36%; 95% confidence interval, 25%-49%) achieved cocaine abstinence. After adjusting for potential confounding factors, generalized estimating equation analyses showed that (1) endothelin-1 (ET-1) levels, a proinflammatory biomarker for endothelial dysfunction, at the 6-month and 12-month visits were significantly lower compared with baseline ET-1 ( P = 0.001 and P < 0.001, respectively), and (2) low-attenuation noncalcified coronary plaque volume, a predictor for myocardial infarction, at 12-month visit was significantly lower compared with baseline low-attenuation noncalcified coronary plaque volume ( P < 0.05). CONCLUSIONS: The findings of this study have not only demonstrated that CM is effective in achieving a sustained reduction in cocaine use, but also provided compelling evidence that reduction in cocaine use leads to quantifiable cardiovascular health benefits, including concurrent decrease in high-risk plaque burden and ET-1, among cocaine users with HIV-associated coronary atherosclerosis.


Subject(s)
Cocaine , Coronary Artery Disease , HIV Infections , Plaque, Atherosclerotic , Humans , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/therapy , HIV , HIV Infections/complications , HIV Infections/therapy , Plaque, Atherosclerotic/diagnostic imaging , Plaque, Atherosclerotic/complications
3.
Cureus ; 14(10): e30872, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36465729

ABSTRACT

Collapsing glomerulopathy is a variant of focal segmental glomerulosclerosis (FSGS) causing rapid renal failure. There has been an emergence of these cases among African American patients with COVID-19, especially those with the apolipoprotein L1 (APOL1) allele. We present a case of an African American patient with COVID-19 who tested positive for the APOL1 allele in the setting of acute renal deterioration. This provides a partial explanation for the increased burden of kidney failure in this population. As cases of COVID-19 persist, COVID-associated nephropathy (COVAN) should be suspected in patients with acute kidney injury and treatment tailored accordingly.

4.
Cureus ; 14(11): e31863, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36579244

ABSTRACT

Malaria remains a significant global health concern. Non-malarial areas, including North America and Europe, largely report cases in association with recent travel to endemic regions. Though cyclic symptoms and chills are characteristic of the infection, thorough social histories including previous travels is the basic prerequisite for timely diagnosis, treatment initiation, and ultimate prognosis of this potentially life-threatening condition.

5.
Cureus ; 14(7): e26809, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35971349

ABSTRACT

Hashimoto's encephalopathy (HE), also known as steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), is a rare autoimmune disease that remains poorly understood. Here, we report a patient who experienced numerous comatose relapses early in the disease course. Despite prolonged corticotherapy, cognitive deficits have persisted through the two-year post-diagnosis follow-up. This case highlights the protracted nature of HE.

6.
Cureus ; 14(5): e25189, 2022 May.
Article in English | MEDLINE | ID: mdl-35747024

ABSTRACT

Sodium-glucose cotransporter-2 inhibitors have become a great insulin-independent approach for diabetic management. These agents have increasingly been reported to be associated with the onset of acute pancreatitis. Here, we present a suspected case of empagliflozin-induced pancreatitis. Finally, we compile previous reports of suspected cases.

7.
J Mol Cell Cardiol ; 155: 88-98, 2021 06.
Article in English | MEDLINE | ID: mdl-33609538

ABSTRACT

Tip60, a pan-acetyltransferase encoded by the Kat5 gene, is enriched in the myocardium; however, its function in the heart is unknown. In cancer cells, Tip60 acetylates Atm (Ataxia-telangiectasia mutated), enabling its auto-phosphorylation (pAtm), which activates the DNA damage response (DDR). It was recently reported that activation of pAtm at the time of birth induces the DDR in cardiomyocytes (CMs), resulting in proliferative senescence. We therefore hypothesized that Tip60 initiates this process, and that depletion of Tip60 accordingly diminishes the DDR while extending the duration of CM cell-cycle activation. To test this hypothesis, an experimental model was used wherein a Myh6-driven Cre-recombinase transgene was activated on postnatal day 0 (P0) to recombine floxed Kat5 alleles and induce Tip60 depletion in neonatal CMs, without causing pathogenesis. Depletion of Tip60 resulted in reduced numbers of pAtm-positive CMs during the neonatal period, which correlated with reduced numbers of pH2A.X-positive CMs and decreased expression of genes encoding markers of the DDR as well as inflammation. This was accompanied by decreased expression of the cell-cycle inhibitors Meis1 and p27, activation of the cell-cycle in CMs, reduced CM size, and increased numbers of mononuclear/diploid CMs. Increased expression of fetal markers suggested that Tip60 depletion promotes a fetal-like proliferative state. Finally, infarction of Tip60-depleted hearts at P7 revealed improved cardiac function at P39 accompanied by reduced fibrosis, increased CM cell-cycle activation, and reduced apoptosis in the remote zone. These findings indicate that, among its pleiotropic functions, Tip60 induces the DDR in CMs, contributing to proliferative senescence.


Subject(s)
Cell Cycle Checkpoints , DNA Damage , Lysine Acetyltransferase 5/metabolism , Myocytes, Cardiac/metabolism , Trans-Activators/metabolism , Animals , Animals, Newborn , Apoptosis/genetics , Biomarkers , Disease Models, Animal , Echocardiography , Gene Expression , Immunohistochemistry , Lysine Acetyltransferase 5/genetics , Mice , Mice, Transgenic , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/etiology , Myocardial Infarction/metabolism , Myocardial Infarction/pathology , Myocardium/metabolism , Myocardium/pathology , Ploidies , Trans-Activators/genetics , Wound Healing
8.
Int J STD AIDS ; 30(3): 223-230, 2019 03.
Article in English | MEDLINE | ID: mdl-30381028

ABSTRACT

HIV infection and/or antiretroviral therapy may increase the risk of subclinical coronary atherosclerosis. However, patients with chronic kidney disease (CKD) and those without IV access cannot undergo contrast-enhanced coronary CT angiography (CCTA). This study was to explore the relationship between cardiac troponin T (cTnT) levels and the extent of coronary plaque burden, as assessed by CCTA in those with HIV infection. Between June and September 2017, 58 HIV-infected participants were recruited and underwent contrast-enhanced CCTA. cTnT was measured with the Elecsys Troponin T Gen 5 STAT assay, and noncalcified plaque burden was quantified using coronary plaque analysis. Robust regression model was employed to perform primary statistical analysis. Univariate robust regression analysis indicated that male gender, cardiovascular risk score defined by the 2013 ACC/AHA cardiovascular risk score algorithm, and cTnT levels were significantly associated with noncalcified plaque volume index (NCPI). Final robust regression analyses showed that only cTnT (log scale) was independently associated with the NCPI (regression coefficient: 0.0453 with 95% CI: 0.0151, 0.0755, p = 0.003). These results of this study suggest that cTnT may be a promising marker for coronary plaque burden, especially in patients with HIV-associated CKD or without IV access.


Subject(s)
Coronary Artery Disease/blood , HIV Infections/complications , Plaque, Atherosclerotic/diagnostic imaging , Tomography, X-Ray Computed/methods , Troponin T/blood , Biomarkers/blood , Calcinosis/diagnostic imaging , Coronary Artery Disease/diagnostic imaging , Cross-Sectional Studies , Female , HIV Infections/drug therapy , Humans , Male , Middle Aged , Pilot Projects , Plaque, Atherosclerotic/epidemiology , Plaque, Atherosclerotic/etiology
9.
Prog Neuropsychopharmacol Biol Psychiatry ; 84(Pt A): 11-17, 2018 06 08.
Article in English | MEDLINE | ID: mdl-29410247

ABSTRACT

BACKGROUND: Although cocaine use may induce/accelerate HIV-associated comorbidities in HIV-infected individuals on antiretroviral therapy (ART), and that HIV itself may accelerate aging, the issue of whether cocaine use plays a role in HIV-associated aging in HIV-infected cocaine users has not been reported. The goals of this study were (1) to explore factor(s) associated with peripheral blood leukocyte telomere length, a marker of cellular replicative history, and telomere shortening in HIV-infected individuals, and (2) to assess whether cocaine use plays a role in accelerating telomere shortening in cocaine users with HIV infection. METHODS: Between June 2010 and December 2016, 147 HIV-infected participants in Baltimore, Maryland, were enrolled in a cross-sectional study investigating factor(s) associated with telomere length. Of these 147, 93 participated in a follow-up study to examine factor(s) associated with telomere shortening. Robust regression model was used to analyze cross-sectional data and the generalized estimating equation approach was used to analyze follow-up data. RESULTS: Cross-sectional analyses demonstrated that (1) both daily alcohol consumption and use of non-nucleoside reverse transcriptase inhibitors (NNRTIs) were independently associated with telomere length, and cocaine use modified the associations of daily alcohol use and NNRTI use with telomere length. Longitudinal analyses suggested that both daily alcohol consumption and duration of NNRTI use were independently associated with telomere shortening, and (2) cocaine use induced/accelerated telomere shortening in HIV-infected individuals. CONCLUSIONS: Our findings suggest that cocaine use may promote premature aging in HIV-infected individuals who are on ART. Our results emphasize the importance of cocaine abstinence/reduced use, which may retard HIV-associated premature aging.


Subject(s)
Cocaine/adverse effects , HIV Infections/genetics , Telomere Shortening/drug effects , Cross-Sectional Studies , Ethanol/adverse effects , Female , Humans , Longitudinal Studies , Male , Middle Aged , Reverse Transcriptase Inhibitors/adverse effects , Telomere Homeostasis/drug effects
10.
Appl Physiol Nutr Metab ; 42(3): 295-301, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28177748

ABSTRACT

Possible association between Helicobacter pylori infection (HPI) and nonalcoholic fatty liver disease (NAFLD) has been proposed by several studies with inconsistent conclusions. Here, we studied the association between HPI and NAFLD at 3 levels: (i) genetic level; (ii) small molecular level; and (iii) clinical level. Relation data between diseases, genes, and small molecules were acquired from Pathway Studio ResNet Mammalian database. Clinical data were acquired from 2263 elderly South Chinese subjects, including 603 NAFLD patients and 1660 subjects without NAFLD. Results showed that HPI and NAFLD present significantly shared genetic bases (95 genes, p value = 2.5E-72), demonstrating multiple common genetic pathways (enrichment p value ≤ 4.38E-20 for the top 10 pathways). Genetic network analysis suggested that mutual regulation may exist between HPI and NAFLD through 21 out of 95 genes. Furthermore, 85 out of the 95 genes manifested strong interaction with 12 small molecules/drugs that demonstrate effectiveness in treating both diseases. Clinical results showed that HPI rate in the NAFLD group was significantly higher than that in the group without NAFLD (51.9% vs. 43.6%; p value = 4.9E-4). Multivariate logistic regression results supported the observations and suggested that HPI served as a risk factor for NAFLD in the experiment data studied (odds ratio: 1.387, p value = 0.018). Results from this study support the hypothesis that complex biological association may exist between HPI and NAFLD, which partially explains the significant clinical co-incidence in the elderly population of south China.


Subject(s)
Helicobacter Infections/genetics , Non-alcoholic Fatty Liver Disease/genetics , Aged , Asian People , Case-Control Studies , China , Female , Gene Expression Regulation , Gene Regulatory Networks , Gene-Environment Interaction , Helicobacter Infections/complications , Helicobacter Infections/diagnosis , Helicobacter pylori/isolation & purification , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Non-alcoholic Fatty Liver Disease/complications , Non-alcoholic Fatty Liver Disease/diagnosis , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...